Immunology 1992: Vol 76 Index

7 Pages·1992·2 MB·English

Author Index
ABDELHALEEM M. & SABBADINI E. Identification of immuno- BROLIDEN P.A. see NIXON D.F.
suppressive fractions from the rat submandibular salivary gland, 331 BROOKS C.G. see ROBINSON J.H.
ABE T., SUGAYA H., YOSHIMURA K. & NAWA Y. Induction of BROWN S. see SOUVANNAVONG V.
the expulsion of Strongyloides ratti and retention of Nippostrongylus BUCCI C. see LALOR P.
brasiliensis in athymic nude mice by repetitive administration of BURROW P. & NASH A.A. Susceptibility to Theiler’s virus-induced
recombinant interleukin-3, 10 demyelinating disease correlates with astrocyte class II induction
ABRAMOWICZ D. see SCHANDENE L. and antigen presentation, 133
ADAM A. see SOUVANNAVONG V. BURROWS S.R., SUHRBIER A., KHANNA R. & MOSS D.J. Rapid
AHLSTEDT S. see DAHLMAN A. visual assay of cytotoxic T-cell specificity utilizing synthetic peptide
ALBERTI S. see LALOR P. induced T-cell-T-cell killing, 174
ALBERTS V.A. see COFFEY R.G.
ALEGRE M.-L. see SCHANDENE L. CAHILL K. see ROSE B.
ALEXANDROV A.B. see JACKSON A.M. CANNING P.C. see KNOBLOCK K.F.
ALLEN B. see ELSAGHIER A. CAPOBIANCHI M.R. see DI MASSIMO A.M.
ALTMAN A., MALLY M.I. & ISAKOV N. Phorbol ester synergizes CARDY S.M. see ROBERTS A.M.
with Ca?+ ionophore in activation of protein kinase C (PKC) and CARLSSON R. see KRISTENSSON K.
PKC isoenzymes in human T cells and in induction of related CASE M.C. see ROBINSON J.H.
cellular functions, 465 CASSATELLA M.A., TRINCHIERI G., HASSAN N.F., HART-
ALVAREZ-VALLINA L. see MUNOZ-FERNANDEZ M.A. MAN L., SORIO C. & BERTON G. Induction of differentiation of
ANASTASI A.M. see DI MASSIMO A.M. the human myeloid cell line, ML3, by tumour necrosis factor and
ANDERSON R. see SHEPHARD E.G. interferon-gamma is accompanied by enhanced expression of the
ANDREWS E. see VERHAGEN A.M. CD4 protein and messenger RNA, 55
APPELBERG R., ORME I.M., PINTO DE SOUSA M.I. & SILVA CASTELLUCCI G. see SCALISE F.
M.T. In vitro effects of interleukin-4 on interferon-y-induced CEBON J. see HAMILTON J.A.
macrophage activation, 553 CHADEE K. see WANG W.
ARCOLEO F. see CILLARI E. CHALLACOMBE S.J., RAHMAN D., JEFFERY J., DAVIS S.S. &
ARORA R. see SAD S. O’HAGAN D.T. Enhanced secretory IgA and systemic IgG anti-
ASHERSON G.L. & DIELI F. Immune deviation in the mouse: body responses after oral immunization with biodegradable micro-
transfer of selective depression of the contact sensitivity and particles containing antigen, 164
interleukin-2 response with retention of interferon-gamma produc- CHERVENAK R. see SOLOFF R:S.
tion requires CD8* T cells, 427 CHISHOLM G.D. see JACKSON A.M.
CHRISTMAS S.E., BREW R., CROSBY I., GECIM I.E. & SELLS
BACH S. see DI MASSIMO A.M. R.A. Human T cells expressing V8 do not predominantly recognize
BAILEY S. see THOMPSON K.M. DR2 alloantigen, 192
BANKHURST A.D. see WHALEN M.M. CILLARI E., MILANO S., DIELI M., ARCOLEO F., PEREGO R.,
BARCLAY A.N. see McCALL M.N. LEONI F.,GROMOG., SEVERN A. & LIEW F.Y. Thymopentin
BARDEN G. see THOMPSON K.M. reduces the susceptibility of aged mice to cutaneous leishmaniasis by
BATE C.A.W., TAVERNE J., BOOTSMA H.J., MASON R.C.ST H.., modulating CD4 T-cell subsets, 362
SKALKO N., GREGORIADIS G. & PLAYFAIR J.H.L. Anti- CINTRON N.M. see MEEHAN R.T.
bodies against phosphatidylinositol and inositol monophosphate CLARE-SALZLER M. & MULLEN Y. Marked dendritic cell-T cell
specifically inhibit tumour necrosis factor induction by malaria cluster formation in the pancreatic lymph node of the non-obese
exoantigens, 35 diabetic mouse, 478
BAUGHN R.E., WICHER V. & WICHER K. Production of rheuma- COFFEY R.G., WEAKLAND L.L. & ALBERTS V.A. Paradoxical
toid factor in adoptively immune guinea-pigs after challenge with stimulation and inhibition by protein kinase C modulating agents of
Treponema pallidum, 548 lipopolysaccharide evoked production of tumour necrosis factor in
BEHNKE D. see KIRCHEIS R. human monocytes, 48
BERTON G. see CASSATELLA M.A. COLDITZ 1.G. & WATSON D.L. The effect of cytokines and
BERTOTTO A. see SCALISE F. chemotactic agonists on the migration of T lymphocytes into skin,
BETTLER B. see SARFATI M.
BEVAN L.J. see ROBERTS A.M. COLEMAN J.W. see O7DONNELL C.A.
BHARDWAJ N. see PANCHOLI P. COLES G.A. see MACKENZIE R.
BIENENSTOCK J. see PEZZATI P. COLIZZI V. see DI CESARE S.
BOGGS J.M. see HARVEY J.P. COLIZZI V. see DI MASSIMO A.M.
BOL M. see PIETERS R.H.H. COMPSTON D.A:S. see WING M.G.
BONIFACE C. see WILKINSON J.M. CONTENT J. see SCHANDENE L.
BOOTSMA H.J. see BATE C.A.W. CORDELL J.L. see PARKHOUSE R.M.E.
BORREBAECK C.A.K. see KRISTENSSON K. COSTA J.J.. KEFFER J.M., GOFF J.P. & METCALFE D.D.
BRANDON M.R. see VERHAGEN A.M. Aphidicolin-induced proliferative arrest of murine mast cells: mor-
BRETT S., ORRELL J.M., SWANSON BECK, J. & IVANYI J. phological and biochemical changes are not accompanied by
Influence of H-2 genes on growth of Mycobacterium tuberculosis in alterations in cytokine gene induction, 413
the lungs of chronically infected mice, 129 CROSBY I. see CHRISTMAS S.E.
BREVE J. see THEPEN T. CRUPIS. see SCALISE F.
BREW R. see CHRISTMAS S.E. CRUSIAUX A. see SCHANDENE L.
BRICIO T. see MAMPASO F.
BRICKELL P.M. see FAULKNER L. DAHLGREN U.I. see DAHLMAN A.
BRITTA R. see SCALISE F. DAHLMAN A., AHLSTEDT S., HANSON L.A., TELEMO E.,
BROLIDEN K. see NIXON D.F. WOLD A.E. & DAHLGREN U.I. Induction of IgE antibodies and
672 Author Index
T-cell reactivity to ovalbumin in rats colonized with Escherichia coli GONZALEZ A. see MUNOZ-FERNANDEZ M.A.
genetically manipulated to produce ovalbumin, 225 GORDON J. see KATIRA A.
DAVIS S.S. see CHALLACOMBE S.J. GOTTSHALLS.L. & HANSEN P.J. Regulation of leucocyte subpopu-
DAVIS W.C. see NAESSENS J. lations in the sheep endometrium by progesterone, 636
DAYER J.-M. see GIRARDIN E. GRAU G.E. see GIRARDIN E.
DELESPESSE G. see SARFATI M. GREGORIADIS G. see BATE C.A.W.
DEMPSEY D. see SOLOFF R:S. GROMO G. see CILLARI E.
DI CESARE S., POCCIA F., MASTINO A. & COLIZZI V. Surface
expressed heat-shock proteins by stressed or human immunodefi- HADLEY A.G., ZUPANSKA B., KUMPEL B.M. & LEADER K.A.
ciency virus (HIV)-infected lymphoid cells represent the target for The functional activity of FeyRII and FcyRIII on subsets of human
antibody-dependent cellular cytotoxicity, 341 lymphocytes, 446
DI MASSIMO A.M., PLACIDO R., BACH S., ANASTASI A.M., HAMILTON J.A., WHITTY G.A., ROYSTON A.K.M., CEBON J. &
MASTINO A., CAPOBIANCHI M.R. & COLIZZI V. Cytotoxic LAYTON J.E. Interleukin-4 suppresses granulocyte colony-stimu-
activity of intestinal lamina propria lymphocytes on human immu- lating factor and granulocyte-macrophage colony-stimulating fac-
nodeficiency virus (HIV)-infected cells, 117 tor levels in stimulated human monocytes, 566
DIELI F. see ASHERSON G.L. HANSEN P.G.C. see JACKSON G.D.F.
DIELI M. see CILLARI E. HANSEN P.J. see GOTTSHALL S.L.
DOSHI R.N. see WHALEN M.M. HANSON L.A. see DAHLMAN A.
DUPONT E. see SCHANDENE L. HANSSON M. see SITNICKA E.
DZUIBA J. see ROSE B. HARA K. see MATSUKI Y.
HARDARD‘’OTTIR I., WHELAN J. & KINSELLA J.E. Kinetics of
ECKMANN L., MORZYCKA-WROBLEWSKA E., SMITH J.R. & tumour necrosis factor and prostaglandin production by murine
KAGNOFF M.F. Cytokine-induced differentiation of IgA B cells: resident peritoneal macrophages as affected by dietary n-3 polyun-
studies using an IgA expressing B-cell lymphoma, 235 saturated fatty acids, 572
ELSAGHIER A., NOLAN A., ALLEN B. & IVANYI J. Distinctive HART P.H., JONES C.A. & FINLAY-JONES J.J. Interleukin-4
Western blot antibody patterns induced by infection of mice with suppression of monocyte tumour necrosis factor-« production.
individual strains of the Mycobacterium avium complex, 355 Dependence on protein synthesis but not on cyclic AMP production,
ELSON C.J. see LEADER K.A. 560
ERIKSSON M. see SJOSTEDT A. HARTMAN L. see CASSATELLA M.A.
ERIKSSON M. see TARNVIK A. HARVEY J.P., KOO C.H., BOGGS J.M., YOUNG R.N. & GEOTZL
ERLWEIN O. see REICH A. E.J. Mouse monoclonal antibody to a latent epitope of leucocyte
receptors for leukotriene By, 122
FABIETTI G.M. see SCALISE F. HASEGAWA Y. see KAWABE T.
FAITH A., O’HEHIR R.E., MALKOVSKY M. & LAMB J.R. HASSAN N.F. see CASSATELLA M.A.
Analysis oft he basis of resistance and susceptibility of CD4* T cells HAYNES D.R., WHITEHOUSE M.W. & VERNON-ROBERTS B.
to human immunodeficiency virus (HIV)-gp120 induced anergy, 177 The prostaglandin E; analogue, Misoprostol, regulates inflamma-
FAULKNER L., PATEL M., BRICKELL P.M. & KATZ D.R. tory cytokines and immune functions in vitro like the natural
Regulation ofc -/gr messenger RNA levels in U937 cells treated with prostaglandins E,, E2 and E3, 251
different modulating agents, 65 HAYWARD A., SHRIBER M., KUBO R. & MCDUFFIE M. T-cell
FINLAY-JONES J.J. see HART P.H. repopulation following neonatal injection of non-obese diabetic
FLEGO L. see ZOLA H. (NOD) mice with anti-T-cell antibodies, 110
FLEISCHER B. see MITTRUCKER H.-W. HERZENBERG L.A. see LALOR P.
FONTAN G. see MARIN M.A. HOEBEN K. see THEPEN T.
FORNARO M. see LALOR P. HOFSTETTER H. see SARFATI M.
FOURNIER S. see SARFATI M. HOLMDAHL R., GOLDSCHMIDT T.J., KLEINAU S., KVICK C.
FRESNO M. see MUNOZ-FERNANDEZ M.A. & JONSSON R. Arthritis induced in rats with adjuvant oil is a
FRIDKIN M. see SHEPHARD E.G. genetically restricted «f T-cell dependent autoimmune disease, 197
FRIEDL P., KONIG B. & KONIG W. Effects of mucoid and non- HOLMSKOV U., TEISNER B., PEDERSEN N.T., LAURSEN S.B.,
mucoid Pseudomonas aeruginosa isolates from cystic fibrosis RASMUSSEN H.B. & JENSENIUS J.C. Tissue localization of
patients on inflammatory mediator release from human polymor- conglutinin, a bovine C-type lectin, 169
phonuclear granulocytes and rat mast cells, 86 HUTCHINSON L.V. see SUTTON P.
FUJII S. see MAKINO S.
FUJIWARA M. see MATSUMOTO Y. IMAI Y. see YAMAKAWA M.
FUSE Y. see IMAZEKI N. IMAZEKIN., SENOO A. & FUSE Y. Is the follicular dendritic cell a
primarily stationary cell? 508
GAGNON N. see STANKOVA J. ISAKOV N. see ALTMAN A.
GALEA-LAURI J. see WILKINSON J.M. ISOBE K.-I. see KAWABE T.
GALLATI H. see GIRARDIN E. ISSEKUTZ A.C. & ISSEKUTZ T.B. The contribution of LFA-1
GAMBON F. see MUNOZ-FERNANDEZ M.A. (CD11a/CD18) and MAC-1 (CD11b/CD18) to the in vivo migration
GAO Y. see LEARY T.P. of polymorphonuclear leucocytes to inflammatory reactions in the
GECIM L.E. see CHRISTMAS S.E. rat, 665
GEOTZL E.J. see HARVEY J.P. ISSEKUTZ T.B. see ISSEKUTZ A.C.
GERLI R. see SCALISE F. IVANYI J. see BRETT S.
GEWURX B.E. see YING S.-C. IVANYI J. see ELSAGHIER A.
GEWURZ A.T. see YING S.-C.
GEWURZ H. see YING S.-C. JACKSON A.M., ALEXANDROV A.B., PRESCOTT S., JAMES K.
GILLESPIE A. see ROSE B. & CHISHOLM G.D. Role of adhesion molecules in lymphokine-
GIRARDIN E., ROUX-LOMBARD P., GRAU G.E., SUTER P., activated killer cell killing of bladder cancer cells: further evidence
GALLATI H., THE JS STUDY GROUP & DAYER J.-M. for a third ligand for leucocyte function-associated antigen-1, 286
Imbalance between tumour necrosis factor-alpha and soluble JACKSON G.D.F., HANSEN P.G.C. & UNDERDOWN B.J. Further
TNF receptor concentrations in severe meningococcaemia, 20 evidence that hepatic sources confer biliary antibody in the rat, 397
GOFF J.P. see COSTA J.J. JAMES K. see JACKSON A.M.
GOLDMAN M. see SCHANDENE L. JEFFERY J. see CHALLACOMBE S.J.
GOLDSCHMIDT T.J. see HOLMDAHL R. JENNINGS S.R. see SOLOFF R.S.
Author Index 673
JENSENIUS J.C. see HOLMSKOV U. McCALL M.N., SHOTTON D.M. & BARCLAY A.N. Expression of
JIANG H. see YING S.-C. soluble isoforms of rat CD45. Analysis by electron microscopy and
JONES C.A. see HART P.H. use in epitope mapping of anti-CD45R monoclonal antibodies, 310
JONSSON R. see HOLMDAHL R. McDUFFIE M. see HAYWARD A.
MACHT L.M. see LEADER K.A.
KAGNOFF M.F. see ECKMANN L. MACHUGH N. see NAESSENS J.
KAMAL M. see KATIRA A. MACKENZIE R., COLES G.A., TOPLEY N., POWELL WS. &
KATAGIRI T. see KIMURA K. WILLIAMS J.D. Down-regulation of cyclooxygenase product
KATIRA A., KAMAL M. & GORDON J. Occupancy of CD72 (the generation by human peritoneal macrophages, 648
CDS counterstructure) enchances interleukin-4-dependent CD23 MAEKAWA N. see MAKINO S.
expression in resting B lymphocytes, 422 MAGOULAS T. see TO S.S.T.
KATZ D.R. see FAULKNER L. MAKINO S., MASUTANI H., MAEKAWA N., KONISHI I., FUJII
KAWABE T., ISOBE K.-I., HASEGAWA Y., NAKASHIMA I. & S.. YAMAMOTO R. & YODOI J. Adult T-cell leukaemia-derived
SHIMOKATA K. Immunosuppressive activity induced by nitric factor/thioredoxin expression on the HTLV-I transformed T-cell
oxide in culture supernatant of activated rat alveolar macrophages, lines: heterogeneous expression in ATL-2 cells, 578
72 MALKOVSKY M. see FAITH A.
KEFFER J.M. see COSTA J.J. MALLY M.I. see ALTMAN A.
KELLEY K. see ROSE B. MAMPASO F., BRICIO T., MARTIN A. & MOLINA A. Production
KHANNA R. see BURROWS S.R. of interleukin-1-like cytokine by cultured rat glomerular macro-
KIMURA K., OGATA Y., SHIMADA K., WAKABAYASHI T., phages, 408
ONODA H., KATAGIRI T. & MATSUZAWA A. Nephritogeni- MARCHALONIS J.J. see YING S.-C.
city of the /pr® gene on the MRL background, 498 MARCINKIEWICZ J., OLSZOWSKA E., OLSZOWSKI S. &
KINSELLA J.E. see HARDARD’OTTIR I. ZGLICZYNSKI J.M. Enhancement of trinitrophenyl-specific
KIRCHEIS R., MILLECK J., KOROBKO V.G., SHINGAROVA humoral response to TNP proteins as the result of carrier chlori-
L.N., BEHNKE D. & SCHMIDT H.E. Biological activity of nation, 385
mutants of human tumour necrosis factor-alpha, 433 MARIN M.A., FONTAN G. & LOPEZ-TRASCASA M. Require-
KLEINAU S. see HOLMDAHL R. ments for the production of high-titre C3 nephritic factor (NEF)
KNOBLOCK K.F. & CANNING P.C. Modulation of in vitro porcine antibody in vitro, 318
natural killer cell activity by recombinant interleukin-l«, inter- MARSHALL JS. see PEZZATI P.
leukin-2 and interleukin-4, 299 MARTIN A. see MAMPASO F.
KONIG B. see FRIEDL P. MASON D.Y. see PARKHOUSE R.M.E.
KONIG W. see FRIEDL P. MASON R.C.ST H. see BATE C.A.W.
KONISHI I. see MAKINO S. MASTINO A. see DI CESARE S.
KOO C.H. see HARVEY J.P. MASTINO A. see DI MASSIMO A.M.
KOROBKO V.G. see KIRCHEIS R. MASUTANI H. see MAKINO S.
KRAAL G. see THEPEN T. MATSUKI Y., YAMAMOTOT. & HARA K. Detection ofi nflamma-
KRAUS E.T. see MEEHAN R.T. tory cytokine messenger RNA (mRNA)-expressing cells in human
KRISTENSSON K., BORREBAECK C.A.K. & CARLSSON R. inflamed gingiva by combined in situ hybridization and immunohis-
Human CD4* T cells expressing CD45RA acquire the lymphokine tochemistry, 42
gene expression of CD45RO* T-helper cells after activation in vitro, MATSUMOTO Y., OHMORI K. & FUJIWARA M. Immune regula-
103 tion by brain cells in the central nervous system: microglia but not
KUBO R. see HAYWARD A. astrocytes present myelin basic protein to encephalitogenic T cells
KUMPEL B.M. see HADLEY A.G. under in vivo-mimicking conditions, 209
KUMPEL B.M. see LEADER K.A. MATSUZAWA A. see KIMURA K.
KURASHIGE T. see TOMODA T. MEEHAN R.T., NEALEL.S., KRAUS E.T., STUART C.A., SMITH
KURIMOTO I. see YOSHIKAWA T. M.L., CINTRON N.M. & SAMS C.F. Alteration in human mono-
KVICK C. see HOLMDAHL R. nuclear leucocytes following space flight, 491
MELAMED M.D. see THOMPSON K.M.
LACHMANN P.J. see WING M.G. METCALFE D.D. see COSTA J.J.
LALOR P., BUCCI C., FORNARO M., RATTAZZI M.C., NAKAU- METCALFE S. see RICHARDS F.M.
CHI H., HERZENBERG L.A. & ALBERTI S. Molecular cloning, MILANO S. see CILLARI E.
reconstruction and expression of the gene encoding the alpha-chain MILLECK J. see KIRCHEIS R.
of the bovine CD8—¢definition oft he three peptide regions conserved MILNER J. see RICHARDS F.M.
across species, 95 MITTRUCKER H.-W. & FLEISCHER B. Functional localization of
LAM B.W. see PIETERS R.H.H. an exocytosis-triggering G-protein in human cytotoxic T lympho-
LAMB J.R. see FAITH A. cytes, 610
LAURSEN S.B. see HOLMSKOV U. MOHAPATRA SS. see ZHANG L.
LAYTON J.E. see HAMILTON J.A. MOLINA A. see MAMPASO F.
LEADER K.A. see HADLEY A.G. MORGAN B.P. see ROONEY I.A.
LEADER K.A., MACHT L.M., STEERS F., KUMPEL B.M.- & MORZYCKA-WROBLEWSKA E. see ECKMANN L.
ELSON C.J. Antibody responses to the blood group antigen D in MOSS D.J. see BURROWS S.R.
SCID mice reconstituted with human blood mononuclear cells, 229 MULLEN Y. see CLARE-SALZLER M.
LEARY T.P., GAO Y. & SPLITTER G.A. Constitutively expressing MUNOZ-FERNANDEZ M.A., PIMENTEL-MUINOS F.X., GON-
cell lines that secrete a truncated bovine herpes virus-1 glycoprotein ZALEZ A., GAMBON F., ALVAREZ-VALLINA L. & FRESNO
(gpl) stimulate T-lymphocyte responsiveness, 367 M. Differential effect of tumour necrosis factor on human thymocyte
LEMLEY P.V. & WRIGHT D.C. Mice are actively immunized after subpopulations, 439
passive monoclonal antibody prophylaxis and ricin toxin challenge, MURAKAMI S. see SHIMABUKURO Y.
S11
LEONI F. see CILLARI E. NAESSENS J., SILEGHEM M., MACHUGH N., PARK Y.H.,
LETELLIER M. see SARFATI M. DAVIS W.C. & TOYE P. Selection of BoCD25 monoclonal
LIEBERT U.G. see REICH A. antibodies by screening mouse L cells transfected with the bovine
LIEW F.Y. see CILLARI E. p55-interleukin-2 (IL-2) receptor gene, 305
LOPEZ-TRASCASA M. see MARIN M.A. NAKASHIMA I. see KAWABE T.
674 Author Index
NAKAUCHI H. see LALOR P. ROBERTS A.M., VAN REE R., CARDY S.M., BEVAN L.J. &
NASH A.A. see BURROW P. WALKER M.R. Recombinant pollen allergens from Dactylis
NASH A.D. see VERHAGEN A.M. glomerata: prelimary evidence that human IgE cross-reactivity
NAWA Y. see ABE T. between Dac g II and Lol p I/II is increased following grass pollen
NEALE L.S. see MEEHAN R.T. immunotherapy, 389
NI K. see O'NEILL H.C. ROBINSON J.H., CASE M.C. & BROOKS C.G. Palmitic acid
NICHOLSON E. see TO S.S.T. conjugation of a protein antigen enhances major histocompatibility
NIEWIESK S. see REICH A. complex class II-restricted presentation to T cells, 593
NIXON D.F., BROLIDEN K., OGG G. & BROLIDEN P.A. Cellular ROLA-PLESZCZYNSKI M. see STANKOVA J.
and humoral antigenic epitopes in HIV and SIV, 515 ROONEY I.A. & MORGAN B.P. Characterization of the membrane
NOLAN A. see ELSAGHIER A. attack complex inhibitory protein CD59 antigen on human amniotic
cells and in amniotic fluid, 541
O'DONNELL C.A. & COLEMAN J.W. A T-cell response to the anti- ROSE B., GILLESPIE A., WUNDERLICH D., KELLEY K.,
arthritic drug peniciliamine in the mouse: requirements for genera- DZUIBA J., SHEDD D., CAHILL K. & ZERLER B. Differential
tion of the drug-derived antigen, 604 effects of a murine and chimeric mouse/human anti-interleukin-2
O’HAGAN D.T. see CHALLACOMBE S.J. receptor antibody on human T-cell proliferation, 452
O’HEHIR R.E. see FAITH A. ROSEN O. see SHEPHARD E.G.
O'NEILL H.C., NI K. & O’NEILL T.J. Lymphoid precursor cell lines ROUX-LOMBARD P. see GIRARDIN E.
have capacity to migrate to multiple lymphoid sites, 631 ROYSTON A.K.M. see HAMILTON J.A.
O'NEILL T.J. see O'NEILL H.C. RUBIO-TRUJILLO M. see SARFATI M.
OGATA Y. see KIMURA K. RUIS N.M. see VALONE F.H.
OGG G. see NIXON D.F.
OHMORI K. see MATSUMOTO Y. SABBADINI E. see ABDELHALEEM M.
OKADA H. see SHIMABUKURO Y. SADS., RAO K., ARORA R., TALWAR G.P. & RAGHUPATHY R.
OLSZOWSKA E. see MARCINKIEWICZ J. Bypass of carrier-induced epitope-specific suppression using a T-
OLSZOWSKI S. see MARCINKIEWICZ J. helper epitope, 599
ONODA H. see KIMURA K. SAMS C.F. see MEEHAN R.T.
ORME LM. see APPELBERG R. SANDSTROM G. see SJOSTEDT A.
ORRELL J.M. see BRETT S. SANDSTROM G. see TARNVIK A.
SARFATI M., BETTLER B., LETELLIER M., FOURNIER S.,
PANCHOLIP., STEINMAN R.M. & BHARDWAJ N. Dendritic cells RUBIO-TRUJILLO M., HOFSTETTER H. & DELESPESSE G.
efficiently immunoselect mycobacterial-reactive T cells in human Native and recombinant soluble CD23 fragments with IgE suppres-
blood, including clonable antigen-reactive precursors, 217 sive activity, 662
PARK Y.H. see NAESSENS J. SCALISE F., GERLI R., CASTELLUCCI G., SPINOZZI F.,
PARKHOUSE R.M.E., PREECE G., SUTTON R., CORDELL J.L. FABIETTI G.M., CRUPI S., SENSI L., BRITTA R., VACCARO
& MASON D.Y. Relative expression of surface IgM, IgD and the R. & BERTOTTO A. Lymphocytes bearing the 76 T-cell receptor in
Ig-associating «(mb-1) and B(B-29) polypeptide chains, 535 acute toxoplasmosis, 668
PATEL M. see FAULKNER L. SCHANDENE L., VANDENBUSSCHE P., CRUSIAUX A.,
PEDERSEN N.T. see HOLMSKOV U. ALEGREM.-L., ABRAMOWICZD., DUPONT E., CONTENT.
PENNINKS A.H. see PIETERS R.H.H. & GOLDMAN M. Differential effects of pentoxifylline on the pro-
PEREGO R. see CILLARI E. duction of tumour necrosis factor-alpha (TNF-a) and interleukin-6
PEZZATI P., STANISZ A.M., MARSHALL J.S., BIENENSTOCK J. (IL-6) by monocytes and T cell, 30
& STEAD R.H. Expression of nerve growth factor receptor SCHMIDT H.E. see KIRCHEIS R.
immunoreactivity on follicular dendritic cells from human mucosa SCHRIEBER L. see TO S.S.T.
associated lymphoid tissues, 485 SEHON A.H. see ZHANG L.
PIETERS R.H.H., BOL M., LAM B.W., SEINEN W. & PENNINKS SEILLY D.J. see WING M.G.
A.H. The organotin-induced thymus atrophy, characterized by SEINEN W. see PIETERS R.H.H.
depletion of CD4* CD8* thymocytes, is preceded by a reduction of SELLARS R.A. see WILKINSON J.M.
the immature CD4~ CD8* TcRaf'°* CD22" thymoblast subset, SELLS R.A. see CHRISTMAS S.E.
203 SENOO A. see IMAZEKI N.
PIMENTEL-MUINOS F.X. see MUNOZ-FERNANDEZ M.A. SENSI L. see SCALISE F.
PINTO DE SOUSA M.1I. see APPELBERG R. SEVERN A. see CILLARI E.
PLACIDO R. see DI MASSIMO A.M. SHEDD D. see ROSE B.
PLAYFAIR J.H.L. see BATE C.A.W. SHEPHARD E.G., ANDERSON R., ROSEN O. & FRIDKIN M.
POCCIA F. see DI CESARE S. C-reactive protein (CRP) peptides inactivate enolase in human
POWELL WSS. see MACKENZIE R. neutrophils leading to depletion ofi ntracellular ATP and inhibition
PREECE G. see PARKHOUSE R.M.E. of superoxide generation, 79
PRESCOTT S. see JACKSON A.M. SHIMABUKURO Y., MURAKAMI S. & OKADA H. Interferon-
gamma-dependent immunosuppressive effects of human gingival
QUIGG R.J. Inhibition of the alternative pathway of complement by fibroblasts, 344
glomerular chondroitin sulphate proteoglycan, 373 SHIMADA K. see KIMURA K.
SHIMOKATA K. see KAWABE T.
RAGHUPATHY R. see SAD S. SHINGAROVA L.N. see KIRCHEIS R.
RAHMAN D. see CHALLACOMBE S.J. SHOTTON D.M. see McCALL M.N.
RAO K. see SAD S. SHRIBER M. see HAYWARD A.
RASMUSSEN H.B. see HOLMSKOV U. SIEGEL J.N. see YING S.-C.
RATTAZZI M.C. see LALOR P. SILEGHEM M. see NAESSENS J.
REICH A., ERLWEIN O., NIEWIESK S., TER MEULEN V. & SILVA M.T. see APPELBERG R.
LIEBERT U.G. CD4* T cells control measles virus infection of the SITNICKA E. & HANSSON M. Natural killer (NK) cell activity in
central nervous system, 185 human long-term bone marrow cultures (LTBMC): effects of
RICHARDS F.M., MILNER J. & METCALFE S$. Inhibition of the interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulat-
serine/threonine protein phosphatases PP! and PP2A in lympho- ing factor (GM-CSF) on the progenitor cells, 292
cytes: effect on mRNA levels for interleukin-2, IL-2Ra, krox-24, SJOSTEDT A. see TARNVIK A.
p53, hsc70 and cyclophilin, 642 SJOSTEDT A., ERIKSSON M., SANDSTROM G. & TARNVIK A.
Author Index
Various membrane proteins of Francisella tularensis induce inter- UNDERDOWN B.J. see JACKSON G.D.F.
feron-y production in both CD4* and CD8* T cells of primed
humans, 584 VACCARO R. see SCALISE F.
SKALKON. see BATE C.A.W. VALONE F.H. & RUIS N.M. Stimulation of tumour necrosis factor
SMITH J.R. see ECKMANN L. release by cytotoxic analogues of platelet-activating factor, 24
SMITH M.L. see MEEHAN R.T. VAN REE R. see ROBERTS A.M.
SOLOFF R.S., DEMPSEY D., JENNINGS S.R., WOLCOTT R.M. & VANDENBUSSCHE P. see SCHANDENE L.
CHERVENAK R. Characterization of the progeny of precursor-T VERHAGEN A.M., ANDREWS E., BRANDON M.R. & NASH
(pre-T) cells maintained in vitro by interleukin-3 (IL-3). Develop- A.D. Molecular cloning, expression and characterization of the
ment of T-cell function in vivo, 279 ovine IL-2Ra chain, |
SORIO C. see CASSATELLA M.A. VERNON-ROBERTS B. see HAYNES D.R.
SOUVANNAVONG V., BROWN S. & ADAM A. Interleukin-5
increases the expression ofa lkaline phosphatase activity in murine B WAKABAYASHI T. see KIMURA K.
lymphocytes, 505 WALKER M.R. see ROBERTS A.M.
SPINOZZI F. see SCALISE F. WANG W. & CHADEE K. Entamoeba histolytica alters arachidonic
SPLITTER G.A. see LEARY T.P. acid metabolism in macrophages in vitro and in vivo, 242
STANISZ A.M. see PEZZATI P. WATSON D.L. see COLDITZ I.G.
STANKOVA J., GAGNON N. & ROLA-PLESZCZYNSKI M. WEAKLAND LLL. see COFFEY R.G.
Leukotriene By, augments interleukin-2 receptor-beta (IL-2R) WHALEN M.M., DOSHI R.N. & BANKHURST A.D. Effects of
expression and IL-2Rf-mediated cytotoxic response in human pertussis toxin treatment on human natural killer cell function, 402
peripheral blood lymphocytes, 258 WHELAN J. see HARDARD’OTTIR I.
STANSFIELD A.G. see WOOD P.J. WHITEHOUSE M.W. see HAYNES D.R.
STEAD R.H. see PEZZATI P. WHITTY G.A. see HAMILTON J.A.
STEERS F. see LEADER K.A. WICHER K. see BAUGHN R.E.
STEINMAN R.M. see PANCHOLI P. WICHER V. see BAUGHN R.E.
STODDART R.W. see SUTTON P. WILKINSON J.M., GALEA-LAURI J., SELLARS R.A. & BONI-
STREILEIN J.W. see YOSHIKAWA T. FACE C. Identification and tissue distribution of rabbit leucocyte
STUART C.A. see MEEHAN R.T. antigens recognized by monoclonal antibodies, 625
SUGAYA H. see ABE T. WILLIAMS J.D. see MACKENZIE R.
SUHRBIER A. see BURROWS S.R. WING M.G., ZAJICEK J., SEILLY D.J., COMPSTON D.A:S. &
SUTER P. see GIRARDIN E. LACHMANN P.J. Oligodendrocytes lack glycolipid anchored
SUTHERLAND J. see THOMPSON K.M. proteins which protect them against complement lysis. Restoration
SUTTON P., STODDART R.W. & HUTCHINSON LV. Altered of resistance to lysis by incorporation of CD59, 140
patterns of glycosylation on rat lymphocytes associated with WOLCOTT R.M. see SOLOFF R:S.
activation, 472 WOLD A.E. see DAHLMAN A.
SUTTON R. see PARKHOUSE R.M.E. WOOD P.J. & STANSFIELD A.G. Inhibition of T-cell mediated
SWANSON BECK, J. see BRETT S. cytotoxicity by Novobiocin suggests multiple pathways for both
CD4* and CD8* cytotoxic T cells, 460
TALWAR GP. see SAD S. WRIGHT D.C. see LEMLEY P.V.
TANIGUCHI T. see TOMODA T. WRIGHT M.G. see THOMPSON K.M.
TARNVIK A. see SJOSTEDT A. WUNDERLICH D. see ROSE B.
TARNVIK A., ERIKSSON M., SANDSTROM G. & SJOSTEDT A.
Francisella tularensis—a model for studies of the immune response YAMAKAWA M. & IMAI Y. Complement activation in the follicular
to intracellular bacteria in man, 349 light zone of human lymphoid tissues, 378
TAVERNE J. see BATE C.A.W. YAMAMOTO R. see MAKINO S.
TEISNER B. see HOLMSKOV U. YAMAMOTO T. see MATSUKI Y.
TELEMO E. see DAHLMAN A. YING S.-C., MARCHALONIS J.J., GEWURZ A.T., SIEGEL J.N.,
TER MEULEN V. see REICH A. JIANG H., GEWURX B.E. & GEWURZ H. Reactivity of anti-
THE JS STUDY GROUP see GIRARDIN E. human C-reactive protein (CRP) and serum amyloid P component
THEPEN T., HOEBEN K., BREVE J. & KRAALG. Alveolar macro- (SAP) monoclonal antibodies with limulin and pentraxins of other
phages down-regulate local pulmonary immune responses against species, 324
intratracheally administered T-cell-dependent, but not T-cell-inde- YODOI J. see MAKINO S.
pendent antigens, 60 YOSHIKAWA T., KURIMOTO I. & STREILEIN J.W. Tumour
THOMPSON K.M., SUTHERLAND J., BARDEN G., MELAMED necrosis factor-alpha mediates ultraviolet light B-enhanced express-
M.D., WRIGHT M.G., BAILEY S. & THORPE S.J. Human ion of contact hypersensitivity, 264
monoclonal antibodies specific for blood group antigens demon- YOSHIMURA K. see ABE T.
strate multispecific properties characteristic of natural autoanti- YOUNG R.N. see HARVEY J.P.
bodies, 146
THORPE S.J. see THOMPSON K.M. ZAJICEK J. see WING M.G.
TO S.S.T., MAGOULAS T., NICHOLSON E. & SCHRIEBER L. ZERLER B. see ROSE B.
Identification of ah uman endothelial cell activation antigen that is ZGLICZYNSKI J.M. see MARCINKIEWICZ J.
co-expressed by germinal follicle centre B lymphocytes, 616 ZHANG L., SEHON A.H. & MOHAPATRA SS. Induction of IgE
TOMODA T., KURASHIGE T. & TANIGUCHI T. Stimulatory antibodies in mice with recombinant grass pollen antigens, 158
effect of interleukin-1f on the interferon-gamma-dependent HLA- ZOLA H. & FLEGO L. Expression of interleukin-6 receptor on blood
DR production, 15 lymphocytes without in vitro activation, 338
TOPLEY N. see MACKENZIE R. ZUPANSKA B. see HADLEY A.G.
TOYE P. see NAESSENS J.
TRINCHIERI G. see CASSATELLA M.A.
Subject Index
Active immunization: Dendritic cell-T cell cluster production:
by passive monoclonal antibody prophylaxis, 511 in NOD mice, 478
Allergens, grass pollen: Dendritic cells:
immunogenicity of, 158 selection of mycobacterial-reactive T cells, 217
Alveolar macrophages:
suppression of pulmonary immune responses, 60 Endothelial cell activation antigen:
Anti-D antibodies: activation by germinal follicle centre B lymphocytes, 616
in SCID mice, 229 Epitope suppression, carrier induced:
Anti-interleukin-2 receptor antibodies: bypass using a T-helper epitope, 599
effects on T-cell proliferation, 452 Epitopes, humoral and cellular:
Antibody responses: in human immunodeficiency virus and simian immunodeficiency
in Mycobacterium avium infected mice, 355 virus, 515
Arachidonic acid metabolism:
in amoebiasis, 242 Fey receptors II and III:
Arthritis: functional activity, 446
adjuvant induced, 197
G-protein, exocytosis triggering:
Autoimmune adjuvant-induced arthritis, 197
functional localization in cytotoxic T lymphocyte, 610
Gingiva, human:
Biliary antibody, rat:
cytokine mRNA expressing cells in, 42
hepatic source, 397
Glycosylation patterns:
Brain cells:
on rat lymphocytes, 472
immune regulation by, 209
H-2 genes:
c-{gr mRNA in U937 cells: influence on growth of Mycobacterium tuberculosis, 129
regulation of levels, 65 Heat-shock proteins, produced by stressed or human immunodeficiency
C-reactive protein and serum amyloid P component, monoclonal virus-infected cells:
antibodies to: as targets for antibody-dependent cellular cytotoxicity, 341
reactivity with limulin and pentraxins, 324 HTLV-transformed T-cell lines:
C-reactive protein peptides, effect on intracellular ATP and superoxide ADF /thioredoxin expression on, 578
generation: Human immunodeficiency virus-gp120 induced anergy:
in human neutrophils, 79 basis of resistance and susceptibility to, 177
C3 nephritic factor antibody: Human Vf8* T cells:
requirements for production, 318 and anti-DR2 responses, 192
Carrier chlorination:
enhancement of antibody response, 385 IgE antibodies and T-cell responses to ovalbumin in rats colonized with
CD23 expression, interleukin-4 dependent: ovalbumin-producing Escherichia coli, 225
enhancement by CD27 occupancy, 422 Immune deviation, in the mouse:
CD23, soluble: role of CD8* T cells, 427
with IgE suppressive activity, 662 Immunosuppression, interferon-y-dependent:
CD4* T cells, human: by human gingival fibroblasts, 344
activation in vitro, 103 Immunosuppressive fractions:
CD45, rat: rat salivary gland, 331
soluble isoforms, 310 Inflammatory mediator, release from polymorphonuclear and mast
CD59, membrane attack complex inhibitory protein: cells:
characterization, 541 effect of mucoid and non-mucoid isolates from Pseudomonas
CD8«, bovine: aeruginosa, 86
cloning, 95 Interferon-y:
Complement activation: production induced in human T cells by Francisella tularensis, 584
in follicular light zone of human lymphoid tissues, 378 Interleukin-1f:
Complement, alternative pathway: stimulatory effect on IFN-y-dependent HLA-DR production, 15
inhibition by chondroitin sulphate proteoglycan, 373 Interleukin-1-like cytokine:
Conglutinin: production by rat glomerular macrophages, 408
tissue localization, 169 Interleukin-2 receptor, ovine:
Cyclooxygenase product: characterization, |
down-regulation by macrophages, 648 Interleukin-2 receptor-«, bovine:
Cytokine-induced differentiation of IgA B cells, 235 selection of monoclonal antibodies, 305
Cytotoxic T-cell specificity: Interleukin-3, recombinant:
visual assay, 174 induction of worm expulsion, 10
Interleukin-4:
Demyelinating disease, induced by Theiler’s virus: and granulocyte colony-stimulating factor and granulocyte-macro-
and astrocytes, 133 phage colony-stimulating factor levels, 566
Dendritic cell, follicular: effects on macrophage activation, 553
cellular nature of, 508 suppression of tumour necrosis factor-a production, 560
676
Subject Index 677
Interleukin-S: Pentoxifylline:
stimulation of alkaline phosphatase in B cells, 505 effects on tumour necrosis factor and interleukin-6 production, 30
Interleukin-6 receptor: Phorbol ester:
expression on blood lymphocytes, 338 synergism with calcium ionophore in T-cell activation, 465
Pollen allergens, recombinant:
Leucocyte antigen, rabbit: cross-reactivity, 389
identification and tissue distribution, 625 Polymorphonuclear leucocyte migration:
Leukotriene By, receptors: role of LFA-1 and MAC-1, 655
antibody to latent epitope on, 122 Pre-T-cell progeny:
Lipopeptide: function of, 279
major histocompatibility complex class II-restricted presentation, Progesterone:
effects on endometrical leucocytes, 636
Ipr® gene: Prostagladin E; analogue, misoprostal:
nephritogenicity of, 498 immune regulation by, 251
LTBg:
augmentation of interleukin-2 receptor-f expression, 258 Rheumatoid factor production:
Lymphocyte responsiveness: in adoptively immue guinea-pigs, 548
to secreted bovine herpes virus-1 glycoprotein, 367
Lymphoid cell precursors: Serine/threonine protein phosphatases, inhibition:
migration of, 631 in lymphocytes, 642
Lymphokine-activated killer activity: Space flight:
role of adhesion molecules, 286 alterations in mononuclear leucocytes, 491
Mast cells: T lymphocyte, migration into skin:
proliferative arrest by aphidicolin, 413 effect of cytokines, 272
Measles virus infection: T-cell antigens:
control by CD4 T cells, 185 of intracellular bacteria, 349
Membrane immunoglobulins: T-cell mediated cytotoxicity:
association with transmembrane polypeptide chains, 535: inhibition by Novobiocin, 460
Microparticles, biodegradable: y6 T-cell receptor-bearing lymphocytes:
oral immunization with, 164 in acute toxoplasmosis, 668
Monoclonal antibodies, to blood group antigens: T-cell repopulation:
multispecific properties, 146 after infection of NOD mice with anti-T-cell antibodies, 110
Mucosal lymphocytes: T-cell responses to penicillamine, 604
and human immunodeficiency virus infection, 117 Thymopentin:
Myeloid cell line, human, M3: and CD4 cells in Leishmaniasis, 362
induction of differentiation by tumour necrosis factor, 55 Thymus atrophy:
organotin induced, 203
Natural killer cell activity in long-term bone marrow cultures: Tumour necrosis factor:
effect of interleukin-2 and granulocyte-macrophage colony-stimu- effects on thymocytes, 439
lating factor, 292 release stimulated by analogues of platelet-activating factor, 24
Natural killer cell activity, porcine: Tumour necrosis factor and prostaglandin production:
modulation by cytokines, 299 effect of n-3 fatty acids, 572
Natural killer cells: Tumour necrosis factor induction, by malarial exoantigens:
effects of pertussis toxin on, 402 inhibition by antibodies to phosphatidylinositol and inositol, 35
Nerve growth factor: Tumour necrosis factor production, lipopolysaccharide evoked:
expression on follicular dendritic cells from human mucosa, 485 effect of protein kinase C modulating agents, 48
Nitric oxide: Tumour necrosis factor-a:
immunosuppressive activity, 72 mediation of ultraviolet-enhanced contact hypersensitivity, 264
Tumour necrosis factor-« and soluble TNF receptor:
Oligodendrocytes, lack of anchor proteins: resistance to lysis by concentrations in meningococcaemia, 20
incorporation of CD59, 140 Tumour necrosis factor-«, human:
biological activity of mutants, 433
Penicillamine: Tumour necrosis factor-«, monocyte:
T-cell responses to, 604 suppression by interleukin-4, 560